Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Related structures:
AlphaFold database: A4H9W5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 296 | 300 | PF00656 | 0.649 |
CLV_C14_Caspase3-7 | 97 | 101 | PF00656 | 0.625 |
CLV_NRD_NRD_1 | 104 | 106 | PF00675 | 0.709 |
CLV_NRD_NRD_1 | 157 | 159 | PF00675 | 0.551 |
CLV_NRD_NRD_1 | 179 | 181 | PF00675 | 0.505 |
CLV_NRD_NRD_1 | 190 | 192 | PF00675 | 0.475 |
CLV_NRD_NRD_1 | 214 | 216 | PF00675 | 0.512 |
CLV_NRD_NRD_1 | 266 | 268 | PF00675 | 0.537 |
CLV_NRD_NRD_1 | 302 | 304 | PF00675 | 0.599 |
CLV_NRD_NRD_1 | 334 | 336 | PF00675 | 0.543 |
CLV_NRD_NRD_1 | 375 | 377 | PF00675 | 0.632 |
CLV_NRD_NRD_1 | 387 | 389 | PF00675 | 0.544 |
CLV_NRD_NRD_1 | 397 | 399 | PF00675 | 0.511 |
CLV_NRD_NRD_1 | 69 | 71 | PF00675 | 0.552 |
CLV_PCSK_KEX2_1 | 157 | 159 | PF00082 | 0.579 |
CLV_PCSK_KEX2_1 | 179 | 181 | PF00082 | 0.500 |
CLV_PCSK_KEX2_1 | 189 | 191 | PF00082 | 0.478 |
CLV_PCSK_KEX2_1 | 214 | 216 | PF00082 | 0.535 |
CLV_PCSK_KEX2_1 | 258 | 260 | PF00082 | 0.550 |
CLV_PCSK_KEX2_1 | 265 | 267 | PF00082 | 0.509 |
CLV_PCSK_KEX2_1 | 302 | 304 | PF00082 | 0.627 |
CLV_PCSK_KEX2_1 | 334 | 336 | PF00082 | 0.647 |
CLV_PCSK_KEX2_1 | 377 | 379 | PF00082 | 0.642 |
CLV_PCSK_KEX2_1 | 387 | 389 | PF00082 | 0.572 |
CLV_PCSK_KEX2_1 | 59 | 61 | PF00082 | 0.347 |
CLV_PCSK_KEX2_1 | 69 | 71 | PF00082 | 0.552 |
CLV_PCSK_PC1ET2_1 | 258 | 260 | PF00082 | 0.598 |
CLV_PCSK_PC1ET2_1 | 334 | 336 | PF00082 | 0.707 |
CLV_PCSK_PC1ET2_1 | 377 | 379 | PF00082 | 0.602 |
CLV_PCSK_PC1ET2_1 | 59 | 61 | PF00082 | 0.347 |
CLV_PCSK_PC7_1 | 175 | 181 | PF00082 | 0.580 |
CLV_PCSK_PC7_1 | 185 | 191 | PF00082 | 0.552 |
CLV_PCSK_PC7_1 | 210 | 216 | PF00082 | 0.609 |
CLV_PCSK_PC7_1 | 65 | 71 | PF00082 | 0.642 |
CLV_PCSK_SKI1_1 | 108 | 112 | PF00082 | 0.681 |
CLV_PCSK_SKI1_1 | 137 | 141 | PF00082 | 0.512 |
CLV_PCSK_SKI1_1 | 200 | 204 | PF00082 | 0.608 |
CLV_PCSK_SKI1_1 | 210 | 214 | PF00082 | 0.606 |
CLV_PCSK_SKI1_1 | 416 | 420 | PF00082 | 0.544 |
CLV_PCSK_SKI1_1 | 65 | 69 | PF00082 | 0.636 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.652 |
DEG_SPOP_SBC_1 | 93 | 97 | PF00917 | 0.523 |
DOC_CYCLIN_RxL_1 | 22 | 35 | PF00134 | 0.323 |
DOC_USP7_MATH_1 | 101 | 105 | PF00917 | 0.564 |
DOC_USP7_MATH_1 | 417 | 421 | PF00917 | 0.528 |
DOC_USP7_MATH_1 | 84 | 88 | PF00917 | 0.676 |
DOC_USP7_MATH_1 | 91 | 95 | PF00917 | 0.642 |
DOC_WW_Pin1_4 | 123 | 128 | PF00397 | 0.748 |
DOC_WW_Pin1_4 | 85 | 90 | PF00397 | 0.640 |
LIG_14-3-3_CanoR_1 | 108 | 116 | PF00244 | 0.671 |
LIG_14-3-3_CanoR_1 | 137 | 145 | PF00244 | 0.688 |
LIG_14-3-3_CanoR_1 | 342 | 349 | PF00244 | 0.721 |
LIG_14-3-3_CanoR_1 | 365 | 372 | PF00244 | 0.772 |
LIG_14-3-3_CanoR_1 | 416 | 425 | PF00244 | 0.430 |
LIG_Actin_WH2_2 | 401 | 418 | PF00022 | 0.529 |
LIG_APCC_ABBA_1 | 30 | 35 | PF00400 | 0.323 |
LIG_FHA_1 | 367 | 373 | PF00498 | 0.725 |
LIG_FHA_1 | 399 | 405 | PF00498 | 0.536 |
LIG_FHA_1 | 422 | 428 | PF00498 | 0.670 |
LIG_FHA_2 | 142 | 148 | PF00498 | 0.664 |
LIG_FHA_2 | 366 | 372 | PF00498 | 0.756 |
LIG_FHA_2 | 51 | 57 | PF00498 | 0.440 |
LIG_FHA_2 | 66 | 72 | PF00498 | 0.647 |
LIG_LIR_Gen_1 | 234 | 242 | PF02991 | 0.620 |
LIG_LIR_Gen_1 | 5 | 15 | PF02991 | 0.323 |
LIG_LIR_Nem_3 | 118 | 123 | PF02991 | 0.588 |
LIG_LIR_Nem_3 | 234 | 239 | PF02991 | 0.568 |
LIG_LIR_Nem_3 | 41 | 47 | PF02991 | 0.324 |
LIG_LIR_Nem_3 | 5 | 10 | PF02991 | 0.323 |
LIG_PCNA_PIPBox_1 | 244 | 253 | PF02747 | 0.518 |
LIG_Pex14_2 | 145 | 149 | PF04695 | 0.546 |
LIG_RPA_C_Fungi | 261 | 273 | PF08784 | 0.621 |
LIG_SH2_CRK | 51 | 55 | PF00017 | 0.336 |
LIG_SH2_CRK | 7 | 11 | PF00017 | 0.336 |
LIG_SH2_NCK_1 | 236 | 240 | PF00017 | 0.536 |
LIG_SH2_SRC | 236 | 239 | PF00017 | 0.598 |
LIG_SH2_STAP1 | 169 | 173 | PF00017 | 0.530 |
LIG_SH2_STAP1 | 63 | 67 | PF00017 | 0.485 |
LIG_SH2_STAT5 | 7 | 10 | PF00017 | 0.418 |
LIG_SH3_3 | 83 | 89 | PF00018 | 0.661 |
LIG_TRAF2_1 | 338 | 341 | PF00917 | 0.688 |
LIG_TRAF2_1 | 361 | 364 | PF00917 | 0.733 |
MOD_CK1_1 | 141 | 147 | PF00069 | 0.651 |
MOD_CK1_1 | 421 | 427 | PF00069 | 0.653 |
MOD_CK1_1 | 94 | 100 | PF00069 | 0.570 |
MOD_CK2_1 | 141 | 147 | PF00069 | 0.591 |
MOD_CK2_1 | 214 | 220 | PF00069 | 0.594 |
MOD_CK2_1 | 341 | 347 | PF00069 | 0.702 |
MOD_CK2_1 | 365 | 371 | PF00069 | 0.794 |
MOD_CK2_1 | 65 | 71 | PF00069 | 0.552 |
MOD_GlcNHglycan | 128 | 131 | PF01048 | 0.669 |
MOD_GlcNHglycan | 391 | 397 | PF01048 | 0.665 |
MOD_GlcNHglycan | 420 | 423 | PF01048 | 0.533 |
MOD_GlcNHglycan | 60 | 63 | PF01048 | 0.436 |
MOD_GlcNHglycan | 96 | 99 | PF01048 | 0.650 |
MOD_GSK3_1 | 137 | 144 | PF00069 | 0.494 |
MOD_GSK3_1 | 417 | 424 | PF00069 | 0.431 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.418 |
MOD_PIKK_1 | 253 | 259 | PF00454 | 0.573 |
MOD_PKA_1 | 214 | 220 | PF00069 | 0.379 |
MOD_PKA_1 | 398 | 404 | PF00069 | 0.538 |
MOD_PKA_2 | 214 | 220 | PF00069 | 0.594 |
MOD_PKA_2 | 282 | 288 | PF00069 | 0.642 |
MOD_PKA_2 | 341 | 347 | PF00069 | 0.579 |
MOD_PKA_2 | 366 | 372 | PF00069 | 0.774 |
MOD_Plk_1 | 392 | 398 | PF00069 | 0.662 |
MOD_Plk_2-3 | 341 | 347 | PF00069 | 0.763 |
MOD_Plk_4 | 5 | 11 | PF00069 | 0.418 |
MOD_ProDKin_1 | 123 | 129 | PF00069 | 0.750 |
MOD_ProDKin_1 | 85 | 91 | PF00069 | 0.645 |
MOD_SUMO_for_1 | 165 | 168 | PF00179 | 0.611 |
MOD_SUMO_for_1 | 324 | 327 | PF00179 | 0.728 |
MOD_SUMO_for_1 | 410 | 413 | PF00179 | 0.610 |
MOD_SUMO_rev_2 | 223 | 231 | PF00179 | 0.584 |
MOD_SUMO_rev_2 | 299 | 308 | PF00179 | 0.536 |
MOD_SUMO_rev_2 | 402 | 410 | PF00179 | 0.575 |
MOD_SUMO_rev_2 | 428 | 432 | PF00179 | 0.624 |
TRG_DiLeu_BaEn_4 | 263 | 269 | PF01217 | 0.570 |
TRG_ENDOCYTIC_2 | 236 | 239 | PF00928 | 0.505 |
TRG_ENDOCYTIC_2 | 51 | 54 | PF00928 | 0.323 |
TRG_ENDOCYTIC_2 | 6 | 9 | PF00928 | 0.337 |
TRG_ER_diArg_1 | 156 | 158 | PF00400 | 0.661 |
TRG_ER_diArg_1 | 189 | 191 | PF00400 | 0.539 |
TRG_ER_diArg_1 | 213 | 215 | PF00400 | 0.536 |
TRG_ER_diArg_1 | 265 | 267 | PF00400 | 0.495 |
TRG_ER_diArg_1 | 301 | 303 | PF00400 | 0.629 |
TRG_ER_diArg_1 | 376 | 379 | PF00400 | 0.734 |
TRG_NLS_MonoCore_2 | 104 | 109 | PF00514 | 0.770 |
TRG_Pf-PMV_PEXEL_1 | 249 | 253 | PF00026 | 0.566 |
TRG_Pf-PMV_PEXEL_1 | 259 | 263 | PF00026 | 0.472 |
TRG_Pf-PMV_PEXEL_1 | 266 | 270 | PF00026 | 0.442 |
TRG_Pf-PMV_PEXEL_1 | 350 | 355 | PF00026 | 0.709 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0G8 | Leptomonas seymouri | 71% | 100% |
A0A0S4IRH8 | Bodo saltans | 44% | 97% |
A0A0S4JH45 | Bodo saltans | 27% | 100% |
A0A1X0P7B2 | Trypanosomatidae | 49% | 97% |
A0A3Q8IA51 | Leishmania donovani | 90% | 100% |
A0A3R7MIW9 | Trypanosoma rangeli | 48% | 97% |
D0A0C8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 47% | 98% |
E9AGR0 | Leishmania infantum | 90% | 100% |
E9ARV9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4QDL3 | Leishmania major | 90% | 100% |
V5BWX2 | Trypanosoma cruzi | 50% | 97% |